Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in Prodromal Schizophrenia
NCT00237874Phase 3Completed
- Sponsor
- Yale University
- Start
- Feb 2004
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of aripiprazole in schizophrenia, sponsored by Yale University. Primary endpoint: Scale of Prodromal Symptoms Total Score at 8 weeks. Started Feb 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00237874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237874.